As of 2024-07-27, the Relative Valuation of Meridian Bioscience Inc (VIVO) is 34.51 USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.97 USD, the upside of Meridian Bioscience Inc based on Relative Valuation is 1.6%.
The range of the Relative Valuation is 34.04 - 35.10 USD.
| Range | Selected | |
| Trailing P/E multiples | 35.3x - 36.4x | 35.9x |
| Forward P/E multiples | 32.0x - 32.8x | 32.3x |
| Fair Price | 34.04 - 35.10 | 34.51 |
| Upside | 0.2% - 3.3% | 1.6% |
| Date | P/E |